Starting A Business in Zhangjiang And Talking About The Development Together -- BioEngine Was Interviewed By SMG On The 10th Anniversary Of The Construction Of The Zhangjiang Demonstration Zone
Apr 01, 2021
Leave a message
As a distinguished representative of entrepreneurial development in Zhangjiang, Prof. Tan Wenzong, the founder and chairman of BioEngine, was interviewed by "Zhangjiang Energy Circle", a unique program on the 10th anniversary of the construction of Zhangjiang Demonstration Zone by SMG, sharing his insights and experiences in the six years of entrepreneurship in Zhangjiang.

The picture is a screenshot of the news screen on March 30 Oriental TV
In March 2011, the State Council officially approved the construction of the National Innovation Demonstration Zone in Zhangjiang Hi-tech Zone in Shanghai. After ten years of development, Zhangjiang Demonstration Zone has formed a spatial pattern of "1 zone and 22 parks". As the main battlefield of the Shanghai Science and Technology Innovation Center, Zhangjiang Demonstration Zone insists on combining independent and open innovation and has achieved remarkable results in original innovation, industry cultivation, and radiation drive.
Zhangjiang Demonstration Zone is the cradle of BioEngine's growth and provides a good industrial ecological environment for the steady development of Bechtel. In the six years since its arrival in the core area of Zhangjiang Pharmaceutical Valley, BioEngine has completed the construction of the first phase of the pilot plant, continued to promote the transformation of results, enriched the product line of culture media, and forged ahead towards the goal of becoming the engine of biopharmaceutical development in China. This year, BioEngine took another important step in the transformation of results, and the culture medium factory built in Jinshan Park of Zhangjiang Demonstration Zone will be put into operation soon. With its R&D in Zhangjiang and manufacturing in Shanghai, BioEngine is committed to promoting the rapid development of the biopharmaceutical industry.
Video of the interview is detailed on Knews: http://www.kankanews.com/a/2021-03-30/0039708554.shtml
Source: Shanghai Radio and Television Integrated Media Center
Author: Huiying Chen, Xiao Zhen
Thanks to Huiying Chen, a reporter of Knews, for her support and help to BioEngine.

